The fact that Sirt3 inhibits cardiac hypertrophy was also demonstrated by Sundaresan et al., where the authors proposed that Sirt3 deacetylates FoxO3 in the cytosol and induces nuclear translocation of FoxO3, which promotes transcription of anti-oxidants [3]. The gene discussed is SIRT3; the disease is cardiac hypertrophy.